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Abstract 
Background: Mutations rapidly accumulate in the HIV-1 genome after infection. Some of those mutations are 
selected by host immune responses and often cause viral fitness losses. This study is to investigate whether strongly 
selected mutations that are not associated with immune responses result in fitness losses.
Results: Strongly selected mutations were identified by analyzing 5′-half HIV-1 genome (gag/pol) sequences from 
longitudinal samples of subject CH0131. The K43R mutation in the gag gene was first detected at day 91 post screen-
ing and was fixed in the viral population at day 273 while the synonymous N323tc mutation was first detected at day 
177 and fixed at day 670. No conventional or cryptic T cell responses were detected against either mutation sites by 
ELISpot analysis. However, when fitness costs of both mutations were measured by introducing each mutation into 
their cognate transmitted/founder (T/F) viral genome, the K43R mutation caused a significant fitness loss while the 
N323tc mutation had little impact on viral fitness.
Conclusions: The rapid fixation, the lack of detectable immune responses and the significant fitness cost of the 
K43R mutation suggests that it was strongly selected by host factors other than T cell responses and neutralizing 
antibodies.
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Background
After infection, human immunodeficiency virus type 1 
(HIV-1) rapidly evolves into a quasispecies population 
due to the high level of mutability of the virus and host 
selection pressure. Some of the most  strongly selected 
mutations are associated with  CD8+ T cell responses [1–
5] or neutralizing antibodies (nAbs) [6, 7]. By precisely 
determining T cell responses using peptides based on the 
autologous transmitted/founder (T/F) virus proteome 
sequences in each infected individual and analyzing 
longitudinal near full-length HIV-1 genome sequences 
obtained by single genome amplification (SGA), we pre-
viously found that some predominant or fixed mutations 
were associated with T cell responses [5, 8]. However, 
we also observed that about one-third of rapidly pre-
dominating mutations were not associated with cyto-
toxic T lymphocyte (CTL), especially for those mutations 
not in the env gene [8]. This indicates that host factors 
other than immune responses contribute to the selection 
of those mutations. Investigating the landscape of host 
selection pressure exerting on the HIV-1 genome will 
provide a better understanding of the complex virus-host 
interactions.
Mutations that have a significant fitness cost predomi-
nate because they have a replicative advantage over the 
wild type virus under strong host selection pressure. 
Mutations selected by CTL responses generally impair 
viral fitness [9–13]. Fitness costs of immune escape 
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mutations can have important implications for viral 
pathogenesis, transmission and vaccine development 
[14–21]. By introducing select mutations into their cog-
nate T/F viral genomes, fitness change can be precisely 
determined by a competitive fitness assay. Our previous 
studies showed that both mutations selected by T cell 
and nAb responses significantly affected the fitness of the 
T/F viruses [22–25]. However, whether mutations that 
are not associated with immune selection can affect viral 
fitness has not been studied.
Our previous analysis of longitudinal 5′-half genome 
sequences obtained by SGA from subject CH0131 
showed that strong selection pressure from the host 
drove some mutations to be rapidly fixed in the viral pop-
ulation within 2  years of infection [8]. We showed that 
mutations at two sites were selected by T cell immune 
responses [8] while one was a reversion mutation in 
the TW10 epitope [24]. In this study, we found that the 
earliest mutation K43R in the gag gene in CH0131 was 
strongly selected and rapidly predominated in the viral 
population within 6  months of infection. No conven-
tional or cryptic T cell responses were detected targeting 
this mutation site. However, the mutation caused a sig-
nificant fitness loss. Thus, our results demonstrated that 
host factors other than adaptive immune responses can 
also have strong selection pressure on viral evolution and 
drive genetic diversification of HIV-1 in vivo.
Results
Strongly selected mutations are identified in the 5′‑half 
genome
Analysis of longitudinal 5′-half genome (gag/pol) 
sequences from subject CH0131 (HLA A*29:01, A*23:01, 
B*45:01, B*15:03, Cw*02:02, Cw*06:02) identified muta-
tions that were fixed at five sites in the viral population 
by day 670 post screening (Fig.  1). Mutations (K43R, 
E161Q/S165N, N242T and N323tc) were at four sites in 
the gag gene and one mutation (A980V) was at the end 
of the pol gene. Using autologous overlapping peptides 
based on the T/F whole proteome sequence, we previ-
ously detected  CD8+ T cell responses targeting two T 
cell epitopes  VF9156–164 and  RY10978–986 [8]. By day 670, 
mutations E161Q/S165N and A980V in  VF9156–164 and 
 RY10978–986 epitopes were fixed in the viral population, 
suggesting that these mutations were selected by the T 
cell responses (Fig. 1). However, no T cell responses were 
detected for the regions containing the other three fixed 
mutations. The N242T mutation in the  TW10240–249 
epitope is a reversion mutation [26, 27] since the sub-
ject CH0131 did not have the HLA B*57 allele and was 
infected with the escape mutant virus (Fig.  1) [24]. The 
N242T mutation alone had no detectable impact on fit-
ness of the cognate T/F virus [24].
The K43R mutation, located in an HLA-B*35-restricted 
 WF936–44 epitope (WASRELERF) in Gag [28], was the 
first detected mutation (day 91). It became predominant 
(83%) at day 175 and was fixed in the viral population 
at days 273–670. This indicated that this mutation was 
strongly selected in the host (Figs. 1 and 2a). The synony-
mous N323tc mutation in Gag was first detected at day 
175 and fixed at day 670 (Figs. 1 and 2b).
The K43R and N323tc mutations are not selected by T cell 
responses
Since no T cell responses were detected against the WF9 
epitope using 18-mer peptides with 10 amino acid over-
lap in our previous study [8], we further determined T 
cell responses using various shorter 9-mer peptides con-
taining the K43 site by ELISpot. None of the peptides 
were recognized by the T cells (Fig. 3a). To determine if 
it was selected by cryptic T cell epitopes [29, 30] from 
alternative expression products in the HIV-1 genome, we 
examined all potential open reading frames (ORFs) and 
found that the A → G mutation in the K43 codon (AAA) 
resulted in amino acid substitutions in three alternative 
ORFs (Fig.  3b). To determine if these potentially coded 
proteins were targeted by T cell responses, we tested all 
possible peptides containing the K43R mutation for their 
ability to stimulate T cell responses. None of these pep-
tides could be recognized by T cells from days 23, 93 and 
121 (Fig. 3c). These results demonstrated that the K43R 
mutation was not selected by classic or cryptic T cell 
responses.
T cell responses targeting the site containing the syn-
onymous N323tc mutation were also not detected with 
autologous Gag peptides [8]. To further investigate if this 
mutation was selected by cryptic T cell responses, we 
tested nine peptides from four alternative ORFs (Fig. 4a) 
to determine if these potentially coded proteins were tar-
geted by T cell responses. ELISpot analysis showed that 
none of those peptides were recognized by the T cells 
from days 65 and 602 (Fig.  4b). This suggests that the 
N323tc mutation was also not selected by classic or cryp-
tic T cell responses.
The K43R mutation causes significant fitness loss
One important parameter to evaluate whether a muta-
tion is selected by a host is to determine if it causes fit-
ness loss. A fixed mutation with significant fitness loss 
will indicate a strong host selective pressure. To deter-
mine if the K43R and N323tc mutations affected viral fit-
ness, we introduced each mutation into their cognate T/F 
infectious molecular clone (IMC) [24] and determined 
their fitness costs. The T/F and the two mutant viruses 
replicated equally well in primary  CD4+ T cells when 
cultured individually (Fig.  5a). When the K43R mutant 
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Fig. 1 Highlighter plot of longitudinal 5′-half genome sequences. The single genome amplification (SGA) method was used to infer the trans-
mitted/founder (T/F) 5′-half genome sequence from the screening sample and determine mutations in longitudinal samples. A highlighter plot 
denotes the location of synonymous (green tick), non-synonymous (red ticks), and deletion (grey ticks) mutations in each SGA-derived sequence 
from different time points compared to the T/F virus sequence. The positions of predominant and fixed mutations as well as related T cell epitopes 
are indicated on the bottom. Days post screening are indicated on the left
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was cultured together with the T/F virus, the proportion 
of the K43R mutant gradually decreased while the T/F 
virus gradually increased in the culture. Our model anal-
ysis showed that the K43R mutant was 12% less fit than 
the cognate T/F virus (− 12% ± 1%; p = 0.003 by t test) 
(Fig. 5b). Additional passages showed that the proportion 
of the K43R mutant continuously decreased after each 
passage and was almost completely replaced by the T/F 
virus by passage 3 (Fig.  5c). However, no fitness differ-
ences between the N323tc mutant and the T/F virus were 
observed in the single passage assay (− 0.00% ± 0.01%) 
(Fig.  5d). After three passages, the proportion of the 
N323tc mutant only slightly decreased (Fig.  5e). These 
results demonstrated that the K43R mutation caused a 
significantly fitness loss while the N323tc mutation had 
little impact on viral fitness.
Conclusions
The K43R mutation quickly emerged and was rapidly 
fixed in the viral population after infection in CH0131, 
suggesting that it was strongly selected in the host. 
Because no conventional or cryptic T cell responses were 
detected for the regions containing the K43R mutation 
and that the Gag protein does not elicit neutralizing anti-
bodies, the strong selection pressure on the K43R muta-
tion could not be from adaptive T and B cell responses. 
We have shown clearly that strong immunodominant T 
cell responses exerted the strongest and most rapid selec-
tion pressure in our previous study  [8]. Using the same 
approach, we showed that T cell responses to the WF9 
epitope were absent or at least below the level of detec-
tion in this highly sensitive assay. Therefore, if there 
were T cell responses targeting the K43R site that were 
undetectable (and far from immunodominant), it would 
be difficult to envision how it could exert any significant 
pressure to select such a rapid escape, with a fitness loss.
T cell responses were also not found to target the 
N323tc mutation site, but the mutation had little impact 
on viral fitness. The majority of the N323tc mutation was 
found in the sequences that had the K43R and N242T 
mutations (Fig.  1). Thus, the N323tc mutation was not 
likely selected by the host, but was instead a concurrent 
mutation together with the N242T or K43R mutation.
Analysis of the gag gene sequences in the Los Ala-
mos HIV sequence database (https://www.hiv.lanl.gov) 
showed that R43 was present in 97.3% of the distinct 
viruses while K43 only accounted for 2.2% of the popu-
lation. Since the K43R mutation was found in the WF9 
epitope restricted by the B*35 allele that CH0131 did not 
carry, it was mostly likely a reversion mutation (to the 
consensus of subtype C viruses). However, the significant 
fitness loss of the K43R reversion mutation indicates that 
it was not simply reverted back to the consensus state 
due to the lack of allele-specific selection pressure, but 
instead it was strongly selected in  vivo. We have previ-
ously found that three other reversion mutations (V247I 
and T242N in Gag as well as I64T in Tat) also did not 
cause detectable fitness differences [24, 25]. These results 
demonstrate that reversion mutations alone do not nec-
essarily lead to more fit viruses. The other possibility is 
a b
Fig. 2 Fixed mutations in the gag gene. The fixed K43R (a) and N323tc (b) mutations are indicated with bold letters among longitudinal sequences 
from subject CH0131. Dashes indicate amino acids identical to the T/F virus sequence
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that K43R is a compensatory mutation. It is known that 
the fitness loss caused by some mutations can be restored 
by compensatory mutations [10, 12, 16, 22, 31, 32]. This 
is also not likely since the K43R mutation was the very 
first mutation that selected and fixed in the viral popula-
tion before other mutations were detected in the 5′-half 
genome. Mutations in vpu, env and nef were also detected 
in the 3′-half genome sequences when the K43R muta-
tion was detected [8]. However, it is unlikely that a muta-
tion in the gag gene can compensate fitness losses due to 
mutations in those genes. K43R should not be a compen-
satory mutation for any mutations in LTR because such 
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Fig. 3 Detection of T cell responses targeting the region containing the K43R mutation. a Peptides containing the K43R mutation in the gag open 
reading frames (ORF) were used to detect T cell responses by the IFN-γ ELISpot assay. The dotted line indicates the threshold of a positive ELISpot 
response. b Identification of potential cryptic epitopes in all ORFs at the K43R mutation site. All potential ORFs on both DNA strands were compared 
between the T/F and mutant sequences at the mutation sites. Only a potential ORF at least 11 amino acids long is considered. Compared to the T/F 
sequences, the ORFs with amino acid substitutions (shown in red and blue in T/F sequences and the mutant sequences, respectively, at the muta-
tion sites) are indicated in yellow. c T cell responses were detected with PBMCs from various days post screening and peptides containing potential 
cryptic epitopes at the K43R site by the IFN-γ ELISpot assay
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mutations were not detected in the viral genome. Most 
importantly, since the role of compensatory mutations 
is to restore fitness loss caused by other mutations, they 
alone should not result in fitness losses. Otherwise, they 
will cause additional fitness damage.
Genetic polymorphisms at many sites in the viral 
genome have been found to be associated with NK cell 
responses [33, 34] and anti-Gag antibody responses [35, 
36]. However, specific mutations associated with selec-
tion pressure from NK cells or anti-Gag Ab responses 
have not been clearly identified as those mutations 
selected by T cell responses for in-frame or cryptic 
epitopes or Ab responses against epitopes in Env [1–7, 
37]. Thus, it is unlikely that the K43R mutation was 
selected by NK cell responses and anti-Gag antibody 
responses. It will be important to determine if the K43R 
mutation or similar mutations are selected by NK cell 
responses and anti-Gag antibody responses or by T cell 
responses targeting to the spliced epitopes [38]. While 
only the K43R mutation was fully documented here, 
we found other possible examples of selected escapes 
that were not within an epitope stimulating a measur-
able T cell response in our previous studies [5, 8]. There-
fore, this could be a more widespread phenomenon and 
this study could raise this as an issue for further study. 
Similar mutations should be studied further to increase 
our understanding on how such mutations are strongly 
selected by the host and if the significant fitness loss 
caused by the mutation is associated with lower viral 
loads due to the significantly reduced viral replicative 
capacity.
Methods
Site‑directed mutagenesis
The K43R and N323tc mutants were obtained by intro-
ducing each mutation into the cognate T/F IMC as previ-
ously described [24].
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a
Fig. 4 Detection of T cell responses targeting the region containing the N323tc mutation. a Identification of potential cryptic epitopes in all ORFs 
at the N323tc mutation site. All potential ORFs on both DNA strands were compared between the T/F and mutant sequences at the mutation sites. 
Only a potential ORF at least 11 amino acids long is considered. Compared to the T/F sequences, the ORFs with amino acid substitutions (shown 
in red and blue in T/F sequences and the mutant sequences, respectively, at the mutation sites) are indicated in yellow. b T cell responses were 
detected with PBMCs from various days post screening and peptides containing potential cryptic epitopes at the N323tc site by the IFN-γ ELISpot 
assay. The dotted line indicates the threshold of a positive ELISpot response
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Ex vivo IFN‑γ ELISpot assay
T cell responses to the targeting sites at various days 
post screening in CH0131 were determined using an 
in vitro IFN-γ ELISpot assay as we previously described 
[5, 8]. Peripheral blood mononuclear cells (PBMCs) were 
obtained through leukophereses from healthy donors 
under clinical protocols approved by the Duke University 
Institutional Review Board. ELISpot data are expressed 
as the mean spot forming units (SFU) per million PBMCs 
(SFU/106 PBMC) ± SEM. Positive T cell responses were 
defined as: ≥ 50 SFU/million PBMC and > 4 times above 
background. All assays were performed in triplicate with 
a peptide concentration of 2 μg/ml.
PASS fitness assay
PBMCs were obtained through leukophereses from 
healthy donors under clinical protocols approved by 
the Duke University Institutional Review Board.  CD4+ 
T cells were purified with the QuadroMACS Separa-
tor (Miltenyi Biotec, Auburn, CA) and the  CD4+ T cell 
Isolation Kit II (Miltenyi Biotec, Auburn, CA).  CD4+ T 
cells (5  ×  105 cells) were infected with the mixture of 
two compared viruses (2.5 ng of p24 for each virus) both 
in the single passage and through multiple passages as 
described before [22]. The viral cDNA was synthesized 
with the primer low3 (5′-TTTTTCCTAGGGGCCCTG-
CAATTT-3′; nucleotide (nt) 1998–2021 in HXB2). The 
PASS amplifying primers were the forward primer M6F2 
(5′-Acry-CTCGACGCAGGACTCGGCTTGCTG-3′; 
nt 685–708) and the reverse primer M6R2 (5′-TCCTC-
CCACTCCCTGACATGCTGTCATCATTTC-3′; nt 
1822–1854). The bases were determined with sequencing 
primers juxtaposed to the mutation sites. All assays were 
performed in triplicate.
Modeling relative fitness and statistical analyses
The relative fitness is determined by measuring the rep-
lication slope of each virus in the culture over time using 
the mathematical model and the statistical analysis was 
performed as previously described [22, 24].
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